Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.
A presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.
Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
There are interesting differences in the ways patients of varying ethnicities and races engage with technology.
The sweeping legislation contains tax code reform, health care provisions and climate change action. What does it mean for physicians?
Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.
Nicole Vélez, MD, provided marketing pearls to streamline mundane tasks and promote your practice in the digital world.
Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
A presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.
Boehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.
Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.
Researchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.
Experts describe roflumilast patient selection for plaque psoriasis treatment.
The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.
Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, talk about how clinical approaches and understanding of risk/benefit profiles are evolving in light of the emerging long-term data.
Panelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.
Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Weiss is the managing director of dermatology at OM1, a data analytics company with a health care focus.
As deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.
Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.
Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
2 Clarke Drive Cranbury, NJ 08512